Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up: Results from The DANBIO Registry

Bente Glintborg; Inge Juul Sørensen; Anne Gitte Loft; Jakob Espesen; Hanne Lindegaard; Dorte Vendelbo Jensen; K. Danebod; Sabine Sparre Dieperink; Oliver Hendricks; Inger Marie Jensen Hansen; Asta Linauskas; Salome Kristensen; Lis Smedegaard  Andersen; M. Hossein; H. Nordin; B. L. Andersen; Stavros Chrysidis; J.L. Raun; Natalia  Manilo; Jolanta Grydehøj; E. B. Dalgaard; Dorte Dalsgaard Pedersen; Niels Steen Krogh; Merete Lund Hetland

Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up: Results from The DANBIO Registry

Bente Glintborg, Inge Juul Sørensen, Anne Gitte Loft, Jakob Espesen, Hanne Lindegaard, Dorte Vendelbo Jensen, K. Danebod, Sabine Sparre Dieperink, Oliver Hendricks, Inger Marie Jensen Hansen, Asta Linauskas, Salome Kristensen, Lis Smedegaard Andersen, M. Hossein, H. Nordin, B. L. Andersen, Stavros Chrysidis, J.L. Raun, Natalia Manilo, Jolanta GrydehøjE. B. Dalgaard, Dorte Dalsgaard Pedersen, Niels Steen Krogh, Merete Lund Hetland

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Abstract

Original language	English
Article number	FRI0190
Journal	Annals of the Rheumatic Diseases
Volume	76
Issue number	Suppl. 2
Pages (from-to)	553-554
Number of pages	2
ISSN	0003-4967
Publication status	Published - 2017
Event	Annual European Congress of Rheumatology, European League Against Rheumatism - Madrid, Spain Duration: 14 Jun 2017 → 17 Jun 2017 http://www.congress.eular.org/

Conference

Conference	Annual European Congress of Rheumatology, European League Against Rheumatism
Country/Territory	Spain
City	Madrid
Period	14/06/2017 → 17/06/2017
Internet address	http://www.congress.eular.org/

Access to Document

http://ard.bmj.com/content/annrheumdis/76/Suppl_2/553.2.full.pdf

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Glintborg, B., Sørensen, I. J., Loft, A. G., Espesen, J., Lindegaard, H., Jensen, D. V., Danebod, K., Dieperink, S. S., Hendricks, O., Hansen, I. M. J., Linauskas, A., Kristensen, S., Andersen, L. S., Hossein, M., Nordin, H., Andersen, B. L., Chrysidis, S., Raun, J. L., Manilo, N., ... Hetland, M. L. (2017). Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up: Results from The DANBIO Registry. Annals of the Rheumatic Diseases, 76(Suppl. 2), 553-554. [FRI0190]. http://ard.bmj.com/content/annrheumdis/76/Suppl_2/553.2.full.pdf

@article{f43119f5242a4f8abf60573776452f9c,

title = "Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up: Results from The DANBIO Registry",

author = "Bente Glintborg and S{\o}rensen, {Inge Juul} and Loft, {Anne Gitte} and Jakob Espesen and Hanne Lindegaard and Jensen, {Dorte Vendelbo} and K. Danebod and Dieperink, {Sabine Sparre} and Oliver Hendricks and Hansen, {Inger Marie Jensen} and Asta Linauskas and Salome Kristensen and Andersen, {Lis Smedegaard} and M. Hossein and H. Nordin and Andersen, {B. L.} and Stavros Chrysidis and J.L. Raun and Natalia Manilo and Jolanta Grydeh{\o}j and Dalgaard, {E. B.} and {Dalsgaard Pedersen}, Dorte and Krogh, {Niels Steen} and Hetland, {Merete Lund}",

note = "{\textcopyright} Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.; Annual European Congress of Rheumatology, European League Against Rheumatism, EULAR ; Conference date: 14-06-2017 Through 17-06-2017",

year = "2017",

language = "English",

volume = "76",

pages = "553--554",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 2",

url = "http://www.congress.eular.org/",

}

Glintborg, B, Sørensen, IJ, Loft, AG, Espesen, J, Lindegaard, H, Jensen, DV, Danebod, K, Dieperink, SS, Hendricks, O, Hansen, IMJ, Linauskas, A, Kristensen, S, Andersen, LS, Hossein, M, Nordin, H, Andersen, BL, Chrysidis, S, Raun, JL, Manilo, N, Grydehøj, J, Dalgaard, EB, Dalsgaard Pedersen, D, Krogh, NS & Hetland, ML 2017, 'Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up: Results from The DANBIO Registry', Annals of the Rheumatic Diseases, vol. 76, no. Suppl. 2, FRI0190, pp. 553-554. <http://ard.bmj.com/content/annrheumdis/76/Suppl_2/553.2.full.pdf>

Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up: Results from The DANBIO Registry. / Glintborg, Bente; Sørensen, Inge Juul; Loft, Anne Gitte et al.
In: Annals of the Rheumatic Diseases, Vol. 76, No. Suppl. 2, FRI0190, 2017, p. 553-554.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up

T2 - Annual European Congress of Rheumatology, European League Against Rheumatism

AU - Glintborg, Bente

AU - Sørensen, Inge Juul

AU - Loft, Anne Gitte

AU - Espesen, Jakob

AU - Lindegaard, Hanne

AU - Jensen, Dorte Vendelbo

AU - Danebod, K.

AU - Dieperink, Sabine Sparre

AU - Hendricks, Oliver

AU - Hansen, Inger Marie Jensen

AU - Linauskas, Asta

AU - Kristensen, Salome

AU - Andersen, Lis Smedegaard

AU - Hossein, M.

AU - Nordin, H.

AU - Andersen, B. L.

AU - Chrysidis, Stavros

AU - Raun, J.L.

AU - Manilo, Natalia

AU - Grydehøj, Jolanta

AU - Dalgaard, E. B.

AU - Dalsgaard Pedersen, Dorte

AU - Krogh, Niels Steen

AU - Hetland, Merete Lund

PY - 2017

Y1 - 2017

UR - http://www.congress.eular.org/

M3 - Conference abstract in journal

SN - 0003-4967

VL - 76

SP - 553

EP - 554

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 2

M1 - FRI0190

Y2 - 14 June 2017 through 17 June 2017

ER -

Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up: Results from The DANBIO Registry

Abstract

Conference

Access to Document

AUB Link

Other files and links

Cite this